Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
April 25, 2017
Patent Application Number
14934885
Date Filed
May 7, 2014
Patent Citations Received
Patent Primary Examiner
Patent abstract
Compounds that are Fibroblast Growth Factor Inhibitors (FGFR) and are therefore useful for the treatment of diseases treatable by inhibition of FGFR are disclosed. Also disclosed are pharmaceutical compositions containing such compounds and processes for preparing such compounds.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
